journal article·2019-12-04Open access

A novel strategy to the formulation of carmustine and bioactive nanoparticles co-loaded PLGA biocomposite spheres for targeting drug delivery to glioma treatment and nursing care

Shufeng Yi, Fan Yang, Cunle Jie, Guiqin Zhang

Abstract

Gliomas are the most common brain tumors in humans. Different chemotherapeutics are available to treat gliomas. However, they are costly and pose numerous side effects. The development of nanocomposite based on chemotherapeutic drug and metallic nanoparticle loaded with polymer could be highly useful against glioma. In this study, carmustine loaded with gold NPs and linked with PLGA-PSPE was produced as a bio-nanocomposite and its efficacy in treating glioma and burn wound were investigated. The synthesized biocomposite was characterized by biophysical techniques. It was observed that the synthesized composite was hexagonal and crystalline nature. TGA analysis showed that the particle had good combustible property. Interestingly, the Cm-Au-PLGA-PSPE composite had exhibited remarkable anti-tumor property against U251 human glioma. The flow cytometry showed a greater increase in the apoptosis rate (62.31%) of glioma cells exposed to the bio-nanocomposite. In addition, a greater reduction in the viability of U251 cells was recorded following treatment with Cm-Au-PLGA-PSPE composite. Quick healing of the heart, liver, spleen, lung and kidney tissue wounds in mouse was noticed with Cm-Au-PLGA-PSPE composite treatment. This study concludes that the newly produced Cm-Au-PLGA-PSPE composite would be a promising alternative in treating human gliomas and associated wounds with increased biomedical applications.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurosurgery, Jinan People's Hospital

EICU, Jinan People's Hospital

Dialysis Room, Jinan People's Hospital

Department of Science and Education, Jinan People's Hospital

References (40)

Show source-provided references
1. 10.1002/ana.2242510.1002/ana.22425 ↗
2. 10.1016/j.bbrc.2010.02.04610.1016/j.bbrc.2010.02.046 ↗
3. 10.1002/smll.20040009310.1002/smll.200400093 ↗
4. 10.1021/ja075181k10.1021/ja075181k ↗
5. 10.1146/annurev-bioeng-071811-15012410.1146/annurev-bioeng-071811-150124 ↗
6. 10.1088/0957-4484/19/29/29510410.1088/0957-4484/19/29/295104 ↗
7. 10.1088/0031-9155/55/4/00210.1088/0031-9155/55/4/002 ↗
8. 10.1088/0031-9155/49/18/N0310.1088/0031-9155/49/18/N03 ↗
9. 10.1088/0031-9155/55/11/00410.1088/0031-9155/55/11/004 ↗
10. 10.1016/j.biomaterials.2012.05.04710.1016/j.biomaterials.2012.05.047 ↗
11. 10.1021/la051371210.1021/la0513712 ↗
12. 10.1158/0008-5472.CAN-12-207110.1158/0008-5472.CAN-12-2071 ↗
13. 10.1016/S0305-7372(82)80043-110.1016/S0305-7372(82)80043-1 ↗
14. 10.1002/1097-0142(19830915)52:6<997::AID-CNCR2820520612>3.0.CO;2-210.1002/1097-0142(19830915)52:6<997::AID-CNCR2820520612>3.0.CO;2-2 ↗
15. 10.1227/00006123-200208000-0000910.1227/00006123-200208000-00009 ↗
16. De Vita VT, Carbone PP, Owens AH, et al. Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962. Cancer Res. 1965;25:1876–1881.
17. 10.1378/chest.107.5.135510.1378/chest.107.5.1355 ↗
18. 10.1586/14737140.8.3.34310.1586/14737140.8.3.343 ↗
19. 10.2147/tcrm.s1216045010.2147/tcrm.s12160450 ↗
20. Krupa P, Rehak S, Diaz-Garcia D, et al. Acta Med. 2014;57:142–150.
21. 10.2174/15748921179397999010.2174/157489211793979990 ↗
22. 10.1016/j.carbpol.2007.11.00710.1016/j.carbpol.2007.11.007 ↗
23. Malaikozhundan B, Vaseeharan B, Vijayakumar S, et al. Biological therapeutics of Pongamia pinnata coated zinc oxide nanoparticles against clinically important pathogenic bacteria, fungi and MCF-7 breast cancer cells. MicrobPathog. 2017;104:268–277.
24. 10.3171/2008.7.JNS0847510.3171/2008.7.JNS08475 ↗
25. 10.1097/00000658-196803000-0000410.1097/00000658-196803000-00004 ↗
26. 10.1016/j.saa.2013.08.06610.1016/j.saa.2013.08.066 ↗
27. 10.5185/amlett.2012.icnano.10310.5185/amlett.2012.icnano.103 ↗
28. 10.1016/j.matlet.2008.08.04410.1016/j.matlet.2008.08.044 ↗
29. 10.1016/j.procbio.2011.01.02510.1016/j.procbio.2011.01.025 ↗
30. 10.1016/j.nano.2009.04.00610.1016/j.nano.2009.04.006 ↗
31. 10.1016/j.procbio.2011.07.01110.1016/j.procbio.2011.07.011 ↗
32. 10.1016/j.micpath.2016.09.01010.1016/j.micpath.2016.09.010 ↗
33. 10.1016/j.mtcomm.2017.12.01510.1016/j.mtcomm.2017.12.015 ↗
34. 10.1016/j.nano.2009.05.00910.1016/j.nano.2009.05.009 ↗
35. Chen PY, Liu HL, Hua MY, et al. Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment, Neurol. Oncol. 2010;12:1050–1060.
36. 10.1016/j.ijbiomac.2016.10.11010.1016/j.ijbiomac.2016.10.110 ↗
37. 10.1016/j.carbpol.2013.10.02910.1016/j.carbpol.2013.10.029 ↗
38. 10.1021/la020237410.1021/la0202374 ↗
39. 10.1016/j.jep.2004.09.05110.1016/j.jep.2004.09.051 ↗
40. 10.1016/j.jep.2007.10.03910.1016/j.jep.2007.10.039 ↗